| (Values in U.S. Thousands) | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 |
| Sales | 140 | 660 | 230 | 340 | 480 |
| Sales Growth | -78.79% | +186.96% | -32.35% | -29.17% | +54.84% |
| Net Income | -7,550 | -1,480 | -1,410 | -690 | -3,740 |
| Net Income Growth | -410.14% | -4.96% | -104.35% | +81.55% | -2,068.42% |
Cannapharmarx Inc (CPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
CannaPharmaRX, Inc. is a pharmaceutical company. The company is engaged in cannabinoid discovery, science, research & development. Cannapharmarx Inc., formerly known as Golden Dragon Holding Co., is based in Carneys Point, New Jersey.
Fiscal Year End Date: 12/31